Capsid & Tail
Loading issues…
- Phage therapy for difficult-to-treat infections in children, with Dr. Ameneh KhatamiIn our July PHAVES series, Dr. Ameneh Khatami, a paediatric infectious disease physician and senior lecturer at the University of Sydney, spoke about phage therapy for difficult to treat infections in children. Here’s the recording, along…
- Automating plaque counting with OnePetri using the power of AI — Behind the appThis week, we're featuring a post by Michael Shamash, a graduate student at McGill University in Canada, who developed the new phage plaque counting app OnePetri! He takes us through the story behind the app, how it works, and what its…
- C&T Round Up for August 2021This week, we’re highlighting the three features we published in August! We've got a reflection on African phage scientists' challenges and progress by Raphael Hans Lwesya, a reflection (plus stats!) on Evergreen 2021 (including how to…
- How coevolutionary phage training improves phage efficacyThis week, we're featuring a guest post by Joshua Borin, a UC San Diego PhD Candidate. Joshua takes us behind his recent PNAS paper on how coevolutionary phage training leads to improved phage infectivity.
- Evergreen 2021: Many thanks to all 504 phage phans!Last week, in collaboration with Dr. Betty Kutter and her unstoppable team, we helped run the iconic Evergreen International Phage Meeting — but with a twist — this time it was a hybrid virtual/in-person event! We are overjoyed with how it…
- Problems facing phage technology development in AfricaThis week, we're featuring a guest post by Raphael Hans Lwesya, MSc student at Makerere University in Uganda and founder of thephage.xyz, a new phage-related info hub. Raphael shares his thoughts on phage technology development in Africa,…
- C&T Round Up for July 2021This week, we’re highlighting the four features we published in July! We've got a sneak-peek into the upcoming Evergreen Phage Meeting, a blog post on Phage Directory's new phage research feedback exchange initiative, 'Instill', an…
- Making your company go viral: Adaptive Phage TherapeuticsThis week, Kyle Jackson (PhD student at McMaster University) brings us a profile of Adaptive Phage Therapeutics, the clinical-stage phage biotech company commercializing the US Navy's phage collection. This is the first in a new column Kyle…
- A novel phage with unusual pyrimidine nucleotide substitution: Q&A with Dr. Branko Rihtman and Dr. Richard PuxtyThis week, Madhav Madurantakam Royam interviewed Dr. Branko Rihtman and Dr. Richard Puxty about their new paper describing an unusual nucleotide substitution from deoxythymidine to deoxyuridine in a novel family of phages belonging to…
- Raise your impact with Instill ScienceAre your manuscripts meeting their potential? We're launching a new community initiative called Instill Science to help you raise your impact (and get credit for helping your fellow phage community members do the same).
- You're invited to the Evergreen International Phage Meeting!In case you haven't heard, the Evergreen Phage Meeting is happening both in person and online this year in Olympia, Washington from Aug 1-6. This week, we're highlighting what to expect from this meeting (via a letter from Betty Kutter) and…
- C&T Round Up for June 2021This week, we’re highlighting the three feature articles we published in June: a guest blog post by David Sáez and Lorenzo Corsini on breeding better phages, a recap of a clinical phage therapy case presented in PHAVES by Dr. Laura Damioli…
- Viral Host Range Database: an online tool for recording, analyzing and disseminating virus-host interactionsLast month in our PHAVES series, Quentin Lamy-Besnier, a PhD student in the Debarbieux lab, introduced the Viral Host Range Database their group has developed. This online resource lets you find, document, analyze and distribute information…
- Freedom from antibiotic purgatory? Salvage phage therapy for cure of spinal hardware infectionIn our PHAVES seminar series last month, Dr. Laura Damioli and Dr. Greg Canfield (University of Colorado Anschutz) shared their experience treating their first patient with phage therapy for a spinal hardware infection. Here's the…
- ɛ²-phages: naturally bred high-tech phages which are superior to wild types in critical propertiesThis week, we're featuring a guest blog post by David Sáez and Lorenzo Corsini of PhagoMed; they dive into their recent paper describing how they're breeding phages to be better for therapy using a modified Appelman's protocol.
- C&T Round Up for May 2021This week, we're highlighting the three feature articles we published in May: a 'behind-the-paper' guest post by Steven Sutcliffe and Michael Shamash, a full recap of all six iVoM webinars by Ivone Martins and Luis Melo, and an interview…
- Phages Before the Phrenzy: Part I — An interview with Dr. David Harper, CEO of Evolution BiotechnologiesWhat brought phage therapy to where it is today? This week, we're featuring an interview with Dr. David Harper, CEO of Evolution Biotechnologies, by Curtis Hoffmann, a longtime Phage Directory volunteer. They discuss David's thoughts on…
- Looking back on iVoM: Six webinars covering all aspects of viruses of microbesThis week, we've got highlights and recordings for the six "iVoM" webinars we co-hosted with the VoM/ISVM team from Sept 2020 to March 2021! These webinars included talks by 18 expert speakers and brought together more than 1000 unique…
- Inducing prophages in gut bacteria with common oral medications — Behind the paperThis week, we're featuring a 'behind the paper' article by Steven Sutcliffe and Michael Shamash, graduate students in the Maurice Lab at McGill University. They dive into their new paper on what happens to gut phages when common oral…
- C&T Round Up for April 2021This week, we're highlighting the four feature articles we published in April: virtual event recaps by volunteers Rohit Kongari and Stephanie Lynch, a guide on responding to phage therapy requests, and an opinion piece by Mert Selimoglu on…
